相关实验视频
Updated: May 23, 2025

12:08
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
Published on: May 17, 2019
9.1K
基因原形疫苗计划,抗原专注的生殖中心
Anna Romanov1,2, Grant A Knappe1,3, Larance Ronsard4
1Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
bioRxiv : the preprint server for biology
|March 10, 2025
概括
类似于DNA原始病毒的粒子 (VLPs) 有效地扩展罕见的B细胞,用于HIV广泛中和抗体 (bnAbs). 这种新型疫苗平台避免了支架竞争,增强了前体B细胞成熟,提高了疫苗的疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
- 结构生物学 结构生物学
背景情况:
- 生殖中心 (GCs) 对于疫苗诱导的抗体反应至关重要.
- 对艾滋病毒产生广泛中和抗体 (bnAbs) 需要稀有前体B细胞的扩张.
- 用于多价值免疫原显示的蛋白质支架可以引起不需要的抗体反应.
研究的目的:
- 设计和评估DNA原型病毒样粒子 (VLPs),以最佳地显示HIV Env免疫原体.
- 评估DNA-VLP增强生殖中心B细胞反应的能力,特别是针对亚主导的bnAb前体.
- 在临床前模型中比较DNA-VLP与蛋白质纳米粒子平台的疗效.
主要方法:
- 合理设计的T-独立的DNA-VLP显示生殖线向的HIV Env免疫原 (eOD-GT8).
- 在DNA-VLP结构中纳入T细胞辅助图案.
- 在小鼠模型中进行临床前评估,以评估GC B细胞扩张和抗体前体频率.
- 与临床阶段的蛋白质纳米粒子疫苗进行比较.
主要成果:
- 与蛋白质纳米粒子相比,DNA-VLP显著增加了表位特异性GC B细胞的频率.
- 优化的DNA-VLP促进了GC反应,专注于目标抗原.
- 用DNA-VLP进行一次免疫接种迅速扩大了HIV的亚主导bnAb前体B细胞.
- 避免基架特异性反应增加了bnAb前体B细胞的原始化.
结论:
- DNA-VLP代表了增强疫苗诱导的B细胞对抗HIV等具有挑战性的病原体反应的有希望的平台.
- 消除脚手架免疫性可以改善所需抗体前体种群的扩张.
- DNA-VLP促进了聚焦的GC反应和罕见的,亚主导的B细胞前体的扩张.
相关概念视频
Cells of the Adaptive Immune Response
762
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
762
Diversity of Antigen Receptors
478
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
478
Vaccinations
43.5K
Overview
43.5K
B Cell Activation and Differentiation
1.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.4K
Antigens Involved in Adaptive Immunity
434
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
434

